Elevated blood levels of the chemokine CXCL10 polypeptide are associated with respiratory illnesses (e.g. SARS, influenza and community-acquired pneumonia) and are useful in diagnosis of patients. Methods are provided for diagnosis and treatment of patients suffering from respiratory illnesses. Methods are provided for identifying inhibitors of the CXCL10:CXCR3 axis, for use in treating patients suffering from respiratory illnesses.

 
Web www.patentalert.com

< Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus

> Oral Compositions and Route of Administration for the Delivery of a Thylakoid Extract
~ 00411